The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
July 11th 2025
States have expanded access to over-the-counter ivermectin, raising concerns among health experts about safety, misinformation, and self-medication risks.
Pharmaceutical Industry Giving Attention to Cannabis 'Cousin'
August 1st 2018Ned Milenkovich, PharmD, JD, is chairman of the health care law practice at Much Shelist PC in Chicago, and former vice chairman of the Illinois State Board of Pharmacy. In this video, he discusses hemp, and why it is drawing increased attention from the pharmacuetical industry.
Watch
Alembic: Valsartan Products Not Subject to Recall
July 31st 2018Earlier in the month, FDA officials announced that several, but not all, drug products containing the active ingredient valsartan, were recalled due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled products.
Read More
FDA Okays Iobenguane I-131 for Rare Neuroendocrine Tumors
July 31st 2018The FDA has approved iobenguane I-131 (Azedra) for adult and pediatric patients aged ≥12 years with iobenguane scan–positive, unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (PPGL) who require systemic anticancer therapy.
Read More
Justice Department Places Increased Scrutiny On Pharmacies, Pharmacists
July 30th 2018Federal prosecutors are increasingly turning their attention to pharmacies and pharmacists. In this article, we detail some of the recent enforcement efforts, as well as outline some proactive strategies for compliance.
Read More
Community Outreach at the Drake University College of Pharmacy and Health Sciences
July 26th 2018In this video, Renae Chesnut, EdD, RPh, Dean of the Drake University College of Pharmacy and Health Sciences, discusses the community outreach and volunteering programs in which pharmacy students at her school participate.
Watch